Search results for “Carcinoid syndrome” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 102 patents, we discovered top 23 key players by total patent application. Novartis AG, Ipsen Pharma SAS, Angiogene Pharmaceuticals Ltd. are dominant in this area. They take 41.18% of the total patent filing.
Basel-Stadt, Switzerland
Patent: 18
France
Patent: 14
United Kingdom
Patent: 10
Colorado, United States
Patent: 10
Italy
Patent: 7
United States
Patent: 5
Texas, United States
Patent: 3
Austria
Patent: 3
Kelingyuan Biotechnology (Shenzhen) Co., Ltd.
China
Patent: 3
France
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 1 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Illinois, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 7 patents applied in the last 5 years. We discover 3 most active companies in this area.
Kelingyuan Biotechnology (Shenzhen) Co., Ltd.
China
Patent: 3
Sichuan Sheng, China
Patent: 2
United States
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 7 patents in last 5 years, we discover 2 new entrants.
Kelingyuan Biotechnology (Shenzhen) Co., Ltd.
China
Patent: 3
Sichuan Sheng, China
Patent: 2
Research Institutions
Order by:
Innovation Intensity
No data, please try another search term
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: